Jitendra Ravji Parmar, MD in Eufaula, OK - Medicare Internal Medicine

Jitendra Ravji Parmar, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Eufaula, Oklahoma. He graduated from medical school in 1978 and has 46 years of diverse experience with area of expertise as Internal Medicine. His current practice location is 1 Hospital Dr, Eufaula, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (918) 689-2541.

Jitendra Ravji Parmar is licensed to practice in Oklahoma (license number 15445) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1740273556.

Contact Information

	Jitendra Ravji Parmar, MD
	1 Hospital Dr, Eufaula, OK 74432-4010
	(918) 689-2541
	(918) 689-7285

Physician's Profile

Full Name	Jitendra Ravji Parmar
Gender	Male
Speciality	Internal Medicine
Experience	46 Years
Location	1 Hospital Dr, Eufaula, Oklahoma
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Jitendra Ravji Parmar graduated from medical school in 1978

NPI Data:

NPI Number: 1740273556
Provider Enumeration Date: 08/26/2005
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 2961694112
Enrollment ID: I20101007000143

Medical Identifiers

Medical identifiers for Jitendra Ravji Parmar such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1740273556	NPI	-	NPPES
731262066001	Other	OK	BLUE CROSS BLUE SHIELD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RG0100X	Internal Medicine - Gastroenterology	15445 (Oklahoma)	Primary
207RG0100X	Internal Medicine - Gastroenterology	32240 (Indiana)	Secondary
207RG0100X	Internal Medicine - Gastroenterology	(Illinois)	Secondary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Compassion Home Care, Inc	Stigler, OK	Home health agency
Saint Francis Hospital Muskogee	Muskogee, OK	Hospital

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jitendra Ravji Parmar is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jitendra Ravji Parmar, MD Po Box 629, Eufaula, OK 74432-0629 Ph: (918) 689-2541	Jitendra Ravji Parmar, MD 1 Hospital Dr, Eufaula, OK 74432-4010 Ph: (918) 689-2541

News Archive

Researchers find evidence that protein involved in regulating inflammation has anti-septic effects

Sepsis represents a serious complication of infection and is one of the leading causes of death and critical illness worldwide due in part to the lack of effective therapies. A report in the American Journal of Pathology provides evidence from both mouse and human studies that SHARPIN, a protein involved in regulating inflammation, has anti-septic effects. These findings may spur development of novel sepsis treatments.

Research helps identify stroke patients at risk for mortality and treatments to reduce death rate

For patients who have experienced a large stroke that cuts off blood supply to a large part of the brain, the use of standardized medical management protocol and surgery to decompress swelling can improve life expectancy, Mayo Clinic researchers found in a recent study.

Low doses of amyloid beta protein in healthy brains can cause Alzheimer's disease, say scientists

While too much amyloid beta protein in the brain is linked to the development of Alzheimer's disease, not enough of the protein in healthy brains can cause learning problems and forgetfulness, Saint Louis University scientists have found.

Interim results of a pilot study using BACE cardiac device released

Mardil, Inc. today announced positive interim data from a pilot study investigating the safety and efficacy of its novel cardiac device - BACE (Basal Annuloplasty of the Cardia Externally) - in treating mitral valve regurgitation. The condition arises when the heart's mitral valve leaks blood backward into the heart, causing a range of severe and debilitating symptoms.

Jitendra Ravji Parmar, MD - Medicare Internal Medicine in Eufaula, OK